HOME >> BIOLOGY >> NEWS
Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery

The emerging miniaturized world known as nanomedicine integrates technology, biology and medicine using tools and materials constructed from molecular- and atomic-sized particles too small to seen with a conventional laboratory microscope. Shuming Nie, PhD, professor of biomedical engineering at Emory University and the Georgia Institute of Technology, and director of cancer nanotechnology at Emory's Winship Cancer Institute, will highlight exciting technological breakthroughs in nanomedicine at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. Dr. Nie's talk on "Bioconjugated Nanoparticles for Personalized Medicine: Molecular Imaging, Profiling and Drug Targeting" will be part of a two-day Nanotechnology Seminar at the meeting.

The science of nanotechnology is rapidly moving from its early beginnings in electronics, computers and telecommunications into the expanding field of biomedical nanotechnology. Dr. Nie has been a leader in the nanomedicine field, and has developed semiconductor nanoparticles called quantum dots, which can be bound to particular genes and proteins and used as markers for molecular diagnostics and drug delivery.

"Biomedical nanotechnology is leading to major advances in molecular diagnostics, therapeutics, molecular biology and bioengineering," Dr. Nie says. "Scientists have begun to develop functional nanoparticles that are linked to biological molecules such as peptides, proteins and DNA."

By virtue of their miniature size nanoparticles assume special properties that distinguish them from larger particles, including the ability to emit light in different colors and to act as fluorescent tags. This makes them highly suitable as contrast agents for magnetic resonance imaging (MRI), positron emission tomography (PET) or as fluorescent tracers in optical microscopy. They also may be useful as structural scaffold in tissue engineering.

Although nanoparticles are similar
'"/>

Contact: Ron Sauder
rsauder@emory.edu
404-727-3366
Emory University Health Sciences Center
13-Feb-2004


Page: 1 2

Related biology news :

1. Nanoparticles illuminate brain tumors for days under MRI
2. Nanoparticles could aid biohazard detection, computer industry
3. Nanoparticles in air bad news for people
4. Microarrays, key genome expression trackers, work better when probes are sequence-verified
5. Study probes ecosystem of tree holes
6. UCLA chemists develop new coating for nanoscale probes
7. Shark guide probes uncharted waters
8. Purdue research suggests nanotubes could make better brain probes
9. Carnegie Mellon University receives NASA award to develop probes to detect life on Mars
10. MIT team probes arsenic and old lakes
11. MIT probes cartilage on nanoscale

Post Your Comments:
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, featuring FPC,s ... in 2015 that relate to sales of FPC1155 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... smartphone manufacturer in China and we are ... for Z1 , its ...
(Date:8/6/2015)... Germany , August 6, 2015 ... Instruments (SMI) shows the world,s first Eye ... on Epson,s Moverio BT-200 see-through head mounted display and ... solution, unprecedented quality and efficiency is brought to personalized ... For the first time, professionals and researchers can integrate ...
(Date:8/5/2015)... 2015 The biosensors market is proving highly ... into newer sectors, and development of devices resulting in ... has seen the entry of multiple participants each year ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... the Global Biosensors Market ( http://www.frost.com/nee9 ), finds ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... FRANCISCO , Aug. 26, 2015  Platform ... that it has received a $1.5M Phase II ... (NIH) to further develop its therapeutic agent to ... clinical need in end stage renal disease (ESRD) ... the National Institute of Diabetes and Digestive and ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, ... new business relationships with local sponsors in southern California. The Clinical Trial Management Expert ... development processes and regulatory pathways., , Stem Cell Meeting ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
Cached News: